Understanding FLOGEL® in Nephrostomy Tract Haemostasis Management
Percutaneous nephrolithotomy (PCNL) is considered the gold-standard treatment for large and complex kidney stones and remains the treatment of choice for renal stones > 2 cm. As the incidence of urolithiasis continues to rise globally, PCNL plays a vital role in achieving complete stone clearance.1,2 Despite continuous advancements in surgical techniques and equipment, intraoperative bleeding is still one of the most challenging aspects of the procedure. In tubeless PCNL, effective bleeding control is crucial. Removing the nephrostomy tube can improve patient comfort and speed recovery, but it also increases the need for reliable haemostasis at the nephrostomy tract. To address this challenge, surgeons are increasingly turning to adjunctive haemostatic agents, including flowable gelatin-based matrices such as FLOGEL® . In this blog, we explore how FLOGEL® is used in tubeless PCNL, along with its haemostatic performance and reported clinical outcomes. Press enter or click to v...